The Monitoring Messenger: Mobile Patient Monitoring for the Pediatric Intensive Care Unit

NCT01612091 | Withdrawn

• 1 other identifier: H12-01270
• Study Type: interventional
• Target: N/A
• Locations: 1 country
• Sites: 1

Brief Summary

The Mobile Messenger is a unified, portable and intelligent device that integrates information from multiple patient monitors, mechanical ventilators, infusion pumps and clinical information systems on a mobile platform. It will allow nurses, respiratory therapists and physicians to continuously monitor and coordinate care of critically ill patients. This study will use a participatory design process to guide the design of an integrated mobile device. Next, we will evaluate the proposed device in a simulated ICU setting.

Conditions

Medical Device; User-Computer Interface; Critical Care; Physiologic Monitoring

Keywords

Expert System; Intensive Care; Telemedicine; Equipment Design

Outcome Measures

Primary Outcomes (1)

• Accuracy of priority assignment in triaging task

  Accuracy will be measured by matching of the participants triage priority ranking with the previously defined expert ranking.

  Up to 1 hour

Secondary Outcomes (1)

• Requirements for design of the mobile device

  Up to 2 hours

Study Arms (2)

Monitoring Messenger

EXPERIMENTAL

Device: Monitoring Messenger

Control

ACTIVE COMPARATOR

Traditional tools (monitors, paper records)

Device: Traditional tools

Interventions

Monitoring Messenger DEVICE

Monitoring Messenger prototype device

Monitoring Messenger

Traditional tools DEVICE

Paper based records, screenshots of monitors and therapy devices

Control

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Staff pediatric critical care physicians, pediatric critical care fellow physicians, registered pediatric nurses and respiratory therapists will be eligible to participate in this study
• Subjects willing to provide informed consent

You may not qualify if:

• Inability/failure to provide informed consent.
• Nursing students and resident physicians are not eligible
• For Part II - Simulation Experiment only: Failure to complete the post-training quiz more than twice.
• Evaluation will be immediately discontinued at request of subject at any point during the study.

Sponsors & Collaborators

• University of British Columbia: lead

Study Sites (1)

BC Children's Hospital

Vancouver, British Columbia, V6H 3V4, Canada

Location

Related Links

• Electrical \& Computer Engineering in Medicine (ECEM) website

Study Officials

• Mark Ansermino, MBBCh, FRCPC

  The University of British Columbia

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: BASIC SCIENCE
• Intervention Model: CROSSOVER
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principle Investigator

Study Record Dates

• First Submitted: June 1, 2012
• First Posted: June 5, 2012
• Study Start: November 1, 2013
• Primary Completion: January 1, 2017
• Study Completion: January 1, 2017
• Last Updated: October 26, 2017

Record last verified: 2017-10

Locations

CA (1)